Novel approaches to promote CAR T-cell function in solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel approaches to promote CAR T-cell function in solid tumors

Published:2019-05-10 Issue:8 Volume:19 Page:789-799
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Hull Caroline M¹,Maher John¹²³

Affiliation:

1. School of Cancer and Pharmaceutical Sciences, King’s College London, Division of Cancer Studies, Guy’s Hospital, London, UK

2. Department of Clinical Immunology and Allergy, King’s College Hospital NHS Foundation Trust, London UK

3. Department of Immunology, Eastbourne Hospital, Eastbourne, UK

Funder

the British Lung Foundation

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1614164

Reference132 articles.

1. Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regions

2. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

3. Activation of Resting Human Primary T Cells with Chimeric Receptors: Costimulation from CD28, Inducible Costimulator, CD134, and CD137 in Series with Signals from the TCRζ Chain

4. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruption of SUV39H1-Mediated H3K9 Methylation Sustains CAR T-cell Function;Cancer Discovery;2023-10-31

2. Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review;International Journal of Molecular Sciences;2023-09-30

3. A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma;Translational Oncology;2021-07

4. Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy;Critical Reviews in Oncology/Hematology;2021-01

5. PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges;Biomedicine & Pharmacotherapy;2020-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3